Stocks end higher after two-day decline, Nasdaq lags again


Stock indexes rose in a choppy session, as investors enjoyed data that had March consumer confidence exceeding expectations and hitting a six-year high.

Biotech stocks were again in focus after the group was hit by sharp selling starting on Friday; the iShares biotech ETF bounced between gains and losses to finish slightly higher in heavy volume after sliding 7.5% over the previous two sessions and surging more than 50% over the past year.

The consumer discretionary space saw broad-based selling interest, with retailers lagging while momentum names such as Priceline and Netflix also displayed weakness.

Traders say today's back-and-forth action reflects an environment where few investors are making aggressive bets with the S&P sitting just below record highs.

The dollar held steady against other global currencies, and the yield on the 10-year Treasury note added one basis point to 2.745%.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs